Gov. Laura Kelly and Merck Animal Health — a veterinary medicine company — announced an $895 million expansion project at the ...

Merck (NYSE:MRK) on Thursday announced plans to invest $895M to expand a manufacturing facility in Kansas, becoming the ...

Merck Animal Health, a unit of Merck, said on Thursday it would invest $895 million to expand its manufacturing facility in ...

Merck is expanding domestic manufacturing with a $895 million investment in its Kansas factory, one of several major projects ...

Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...

A new manufacturing plant in De Soto will be a Center of Excellence for the global company, along with expanded R&D ...

The firm reported revenues of $15.53 billion and adjusted earnings per share of $2.22, surpassing consensus predictions of ...

The animal health division of global pharmaceutical company Merck is doubling down on its operations in De Soto.

To keep up with growing demand, ​​Merck Animal Health will invest nearly $900 million to expand its manufacturing facility in ...

It will build a Wilmington, Delaware facility dedicated to making its cancer drug, Keytruda, for U.S. patients.

About two months after receiving a sizable taxpayer-funded grant, Merck & Co. officially announced it would build its newest ...

Merck CEO Robert Davis spoke about the new state-of-the-art biologics center slated to be based in Wilmington, Delaware that ...